Skip to main content

Seattle Biotech Oncothyreon Pays $27 million for Alpine Biosciences

By August 17, 2014April 17th, 2015Portfolio Company News

Seattle biotechnology company Oncothyreon has acquired another local firm, Alpine Biosciences, for about $27 million in stock.

Read the Full Article